Novel Compounds
    1.
    发明申请
    Novel Compounds 审中-公开
    新型化合物

    公开(公告)号:US20100227870A1

    公开(公告)日:2010-09-09

    申请号:US12663739

    申请日:2008-06-12

    CPC分类号: C07D295/185

    摘要: The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof for treating diseases and conditions mediated by positive allosteric modulation of the G-protein coupled metabotropic subtype 5 receptor (mGluR5), such as neurological and psychiatric disorders, for example schizophrenia. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

    摘要翻译: 本发明提供式(I)化合物或其药学上可接受的盐,用于治疗由G-蛋白偶联的代谢型5型受体(mGluR5)的正性变构调节介导的疾病和病症,例如神经和精神疾病,例如精神分裂症 。 此外,本发明涉及含有衍生物的组合物及其制备方法。

    XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS
    8.
    发明申请
    XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS 审中-公开
    XANTHINE衍生物作为选择性HM74A激动剂

    公开(公告)号:US20100099690A1

    公开(公告)日:2010-04-22

    申请号:US12063433

    申请日:2006-08-08

    CPC分类号: C07D473/06 C07D473/04

    摘要: The present invention relates to compounds which are xanthine derivatives, processes for the manufacture of said derivatives, pharmaceutical formulations containing the active compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.

    摘要翻译: 本发明涉及作为黄嘌呤衍生物的化合物,用于制备所述衍生物的方法,含有活性化合物的药物制剂以及该化合物在治疗中的用途,例如用于治疗HM74A受体活化不足的疾病 有助于疾病或受体激活将是有益的。

    Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives
    10.
    发明授权
    Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives 有权
    吡唑并[1,5-A]嘧啶 - 羰基 - 哌嗪衍生物

    公开(公告)号:US08093249B2

    公开(公告)日:2012-01-10

    申请号:US12503135

    申请日:2009-07-15

    IPC分类号: A61K31/497 C07D487/00

    CPC分类号: C07D487/04

    摘要: The present invention relates to novel piperazine derivatives; to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.

    摘要翻译: 本发明涉及新的哌嗪衍生物; 进行准备; 含有该衍生物的药物组合物; 以及在治疗中使用衍生物治疗阻断Cav2.2钙通道有益的疾病。